S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/RTW Investments/Q4 2022

RTW Investments

Periodo: Q4 2022 Β· Depositato: 2023-02-14
Vedi su SEC EDGAR β†—
AUM
$4.90B
Valore totale del portafoglio
Posizioni
77
Titoli dichiarati
Prima Posizione
ALNY
8.2% $400.1M
Var. Trimestrali
+1 / -8
nuovi Β· usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR β€” non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquiditΓ , obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato Γ¨ il valore nozionale delle azioni sottostanti β€” non il premio pagato. CiΓ² sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo Γ¨ tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con β‰₯$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker Γ¨ a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-02-14) si riferisce al titolo sottostante β€” non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ALNYALNYLAM PHARMACEUTICALS INC$400.1M8.17%$233.59$312.78+33.9%
8.2%
RXDXPROMETHEUS BIOSCIENCES INC$369.0M7.53%β€”β€”
7.5%
RCKTROCKET PHARMACEUTICALS INC$346.1M7.07%$19.16$3.84-80.0%
7.1%
IMCRIMMUNOCORE HLDGS PLC$317.3M6.48%$55.42$32.50-41.4%
6.5%
TMOTHERMO FISHER SCIENTIFIC INC$239.8M4.90%$547.18$523.44-4.3%
4.9%
AXSMAXSOME THERAPEUTICS INC$229.9M4.69%$73.32$244.31+233.2%
4.7%
MASIMASIMO CORP$222.2M4.53%$146.03β€”
4.5%
PTCTPTC THERAPEUTICS INC$214.3M4.38%$38.16$83.31+118.3%
4.4%
RAREULTRAGENYX PHARMACEUTICAL IN$183.8M3.75%$45.52$33.47-26.5%
3.8%
ARGXARGENX SE$182.7M3.73%$373.80$939.68+151.4%
3.7%
MRTXMIRATI THERAPEUTICS INC$165.1M3.37%β€”β€”
3.4%
ESTAESTABLISHMENT LABS HLDGS INC$155.9M3.18%$62.72$89.25+42.3%
3.2%
PENPENUMBRA INC$155.4M3.17%$221.20$318.57+44.0%
3.2%
CLDXCELLDEX THERAPEUTICS INC NEW$137.5M2.81%$43.39$38.37-11.6%
2.8%
RNAMAVIDITY BIOSCIENCES INC$124.4M2.54%β€”β€”
2.5%
CYTKCYTOKINETICS INC$118.0M2.41%$44.35$86.49+95.0%
2.4%
ILMNILLUMINA INC$114.1M2.33%$195.40$188.68-3.4%
2.3%
NTRANATERA INC$104.8M2.14%$38.49$279.32+625.7%
2.1%
VCELVERICEL CORP$81.7M1.67%$25.13$46.98+87.0%
1.7%
CUTRQCUTERA INC$79.5M1.62%β€”β€”
1.6%
ACADACADIA PHARMACEUTICALS INC$58.4M1.19%$16.32$25.97+59.1%
1.2%
GMEDGLOBUS MED INC$55.5M1.13%$73.16$80.12+9.5%
1.1%
AXNXAXONICS INC$55.3M1.13%β€”β€”
1.1%
VTYXVENTYX BIOSCIENCES INC$50.9M1.04%β€”β€”
1.0%
RGNXREGENXBIO INC$41.9M0.85%$22.25$13.28-40.3%
0.8%
AVDLXXXXAVADEL PHARMACEUTICALS PLC$41.1M0.84%β€”β€”
0.8%
PTGXPROTAGONIST THERAPEUTICS INC$39.2M0.80%$10.78$131.62+1121.0%
0.8%
ACETADICET BIO INC$37.9M0.77%$137.12$9.00-93.4%
0.8%
PMVPPMV PHARMACEUTICALS INC$37.9M0.77%$8.48$1.22-85.6%
0.8%
TARSTARSUS PHARMACEUTICALS INC$37.4M0.76%$14.42$65.44+353.8%
0.8%

AttivitΓ  Trimestre su Trimestre

Q4 2022 vs. Q3 2022

Nuove Posizioni (1)

TickerEmittenteNozionale
TERNTERNS PHARMACEUTICALS INC$10.2M

Posizioni Chiuse (8)

TickerEmittenteNozionale
TSVT2SEVENTY BIO INC$17.9M
TNDMTANDEM DIABETES CARE INC$15.4M
RCORRENOVACOR INC$7.6M
RACBRESEARCH ALLIANCE CORP II$6.3M
BLSABCLS ACQUISITION CORP$6.1M
FVAM5 01 ACQUISITION CORP$3.9M
LABPLANDOS BIOPHARMA INC$2.6M
EPIXESSA PHARMA INC$2.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
IMTXIMMATICS N.V$3.9M+141.4%
MRTXMIRATI THERAPEUTICS INC$33.6M+93.5%
RAREULTRAGENYX PHARMACEUTICAL IN$86.1M+68.1%-26.5%
AXSMAXSOME THERAPEUTICS INC$145.9M+58.4%+233.2%
IMUXIMMUNIC INC$-3.3M+39.8%
TXG10X GENOMICS INC$13.6M+36.4%
XGNEXAGEN INC$0.4M+30.1%
TARSTARSUS PHARMACEUTICALS INC$2.7M+25.9%+353.8%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
ISEEIVERIC BIO INC$-47.5M-77.3%
GHGUARDANT HEALTH INC$-27.4M-40.6%
SNCESCIENCE 37 HOLDINGS INC$-5.9M-40.3%
LUNGPULMONX CORP$-5.4M-40.3%
RLMDRELMADA THERAPEUTICS INC$-90.7M-21.8%
NYXHNYXOAH S A$-0.8M-21.7%
PTGXPROTAGONIST THERAPEUTICS INC$4.0M-14.0%+1121.0%
DMTKQDERMTECH INC$-7.5M-12.8%
← Torna agli Hedge Fund